Cassvita key facts
as of Oct 2026- Developer of a biotechnology process designed to increase the shelf life of cassava.
- Cassvita is valued at approximately $41.5M as of Oct 2026 (last reported valuation).
- It has raised $15.4M; the latest was Debt - General ($1.8M) in Jul 2025.
- Notable investors include Dorm Room Fund, Harvard Innovation Launch Lab, SBXi, Phoenix Investment Club (San Francisco), Investisseurs & Partenaires — 7 tracked in total.
- Status: Privately Held (backing).
Cassvita's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·Watch Cassvita: the Monday email on marks, rounds and moves
Cassvita funding rounds
No funding rounds for Cassvita are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cassvita valuation
Cassvita's last reported valuation was $41.5 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Cassvita investors
7 investors are on record for Cassvita, including Dorm Room Fund, Harvard Innovation Launch Lab, SBXi and Phoenix Investment Club (San Francisco).
About Cassvita
Developer of a biotechnology process designed to increase the shelf life of cassava. The company's patented technology eradicates climate-related food insecurity and increases shelf life by several months, enabling farmers to increase their harvest and income.
- Sector
- Materials and Resources
- HQ
- Dover, DE, United States
- Founded
- 2020
- Employees
- 21
- Website
- cassvita.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.